Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model

Fatima Amanat; Shirin Strohmeier; Raveen Rathnasinghe; Michael Schotsaert; Lynda Coughlan; Adolfo García-Sastre; Florian Krammer.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-300970

Documentos relacionados

  1. Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model.
  2. Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model.
  3. In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.
  4. A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike.
  5. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.
  6. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
  7. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
  8. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
  9. SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity.
  10. Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation.